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Background: An evidence-based strategy exists to reduce maternal morbidity and mortality associated with severe
pre-eclampsia/eclampsia (PE/E), but it may be difficult to implement in low-resource settings. This study examines
whether facilities that provide emergency obstetric and newborn care (EmONC) in Afghanistan have the capacity to
manage severe PE/E cases.
Methods: A further analysis was conducted of the 2009–10 Afghanistan EmONC Needs Assessment. Assessors
observed equipment and supplies available, and services provided at 78 of the 127 facilities offering comprehensive
EmONC services and interviewed 224 providers. The providers also completed a written case scenario on severe PE/E.
Descriptive statistics were used to summarize facility and provider characteristics. Student t-test, one-way ANOVA,
and chi-square tests were performed to determine whether there were significant differences between facility types,
doctors and midwives, and trained and untrained providers.
Results: The median number of severe PE/E cases in the past year was just 5 (range 0–42) at comprehensive
health centers (CHCs) and district hospitals, compared with 44 (range 0–130) at provincial hospitals and 108
(range 32–540) at regional and specialized hospitals (p < 0.001). Most facilities had the drugs and supplies
needed to treat severe PE/E, including the preferred anticonvulsant, magnesium sulfate (MgSO4). One-third of
the smallest facilities and half of larger facilities reported administering a second-line drug, diazepam, in some
cases. In the case scenario, 96% of doctors and 89% of midwives recognized that MgSO4 should be used to
manage severe PE/E, but 42% of doctors and 58% of midwives also thought diazepam had a role to play.
Providers who were trained on the use of MgSO4 scored significantly higher than untrained providers on six of
20 items in the case scenario. Providers at larger facilities significantly outscored those at smaller facilities on five
items. There was a significant difference between doctors and midwives on only one item: continued use of
anti-hypertensives after convulsions are controlled.
Conclusions: Drugs and supplies needed to treat severe PE/E are widely available at EmONC facilities in
Afghanistan, but providers lack knowledge in some areas, especially concerning the use of MgSO4 and
diazepam. Providers who have specialized training or work at larger facilities are better at managing cases of
severe PE/E. The findings suggest a need to clarify service delivery guidelines, offer refresher training, and
reinforce best practices with supervision and reinforcement.
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The World Health Organization (WHO) estimates that at
least 16% of maternal deaths in low- and middle-income
countries result from hypertensive disorders of pregnancy,
including severe pre-eclampsia and eclampsia (PE/E) [1].
Clinical indications of pre-eclampsia typically present as
high blood pressure and protein in the urine after 20 weeks
gestation. Eclampsia is diagnosed when a pregnant woman
with pre-eclampsia develops convulsions [2]. Although
there are known risk factors for hypertensive disorders of
pregnancy, there is no clinically useful way to predict
which women will develop pre-eclampsia based on clinical
data or biochemical markers [3]. However, high-income
countries have been able to reduce both the incidence of
eclampsia and the case fatality rate associated with it by
90%, using a combination of early detection during ante-
natal care (ANC) and increased access to hospital care for
women who develop severe PE/E [4]. Comparable re-
ductions in rural China and Sri Lanka suggest that this
model—which includes routinely screening pregnant
women for hypertension and proteinuria, treating severe
PE/E with anti-hypertensive and anticonvulsant drugs,
and, if necessary, ending the pregnancy early by inducing
labor or conducting cesarean delivery—can be applied in
low-income countries [5].
Implementing this strategy in a low-resource setting is
challenging, however. First, it requires good quality fo-
cused ANC for all pregnant women in order to detect
cases of severe PE/E, along with increased awareness of
danger signs among women and the community. Since
PE/E can occur during pregnancy, labor, or postpartum,
it is important that detection efforts begin in pregnancy
and continue through labor and the postpartum period.
Second, it demands the presence of skilled birth atten-
dants at antenatal clinics and during births, with ready ac-
cess to emergency obstetric and newborn care (EmONC).
Managing eclampsia with anticonvulsants is one of nine
essential EmONC services—called signal functions—that
directly prevent and/or treat complications associated with
maternal and newborn death. Indeed, routine screening
only makes sense when women diagnosed with severe
pre-eclampsia can be referred to EmONC facilities that
have skilled personnel, supplies, and equipment needed to
treat the condition and induce labor [6]. Finally, address-
ing severe PE/E requires adequate and reliable supplies of
equipment and drugs—to measure blood pressure, test for
proteinuria, and treat PE/E—at every level of the health
system [4]. Magnesium sulfate (MgSO4) is critical, because
it is the drug of choice for preventing convulsions in pre-
eclamptic women and for preventing recurrence of con-
vulsions [7]. Multi-center trials have demonstrated that
this anticonvulsant, which is inexpensive and does not re-
quire special storage, is significantly more effective than
diazepam or other drugs in reducing convulsions,preventing progression from severe pre-eclampsia to
eclampsia, and improving outcomes for mothers and new-
borns [8-10].
In Afghanistan—where the maternal mortality ratio is
high at 327 deaths per 100,000 live births and hypertensive
disorders of pregnancy account for 20% of maternal
deaths [11]—reducing morbidity and mortality from se-
vere PE/E will require systematic changes in women’s
health-seeking behaviors and access to health care, as well
as an increase in the capacity of the health system to offer
ANC and EmONC services. In a recent national survey,
just 48% of Afghan women (77% in urban areas and 41%
in rural areas) reported receiving ANC from a skilled pro-
vider and only 15% made at least four ANC visits, as
recommended by WHO [12]. According to women’s re-
ports, ANC providers were not likely to measure blood
pressure or take urine samples (35% and 24%, respect-
ively). Only one-third of Afghan women delivered in
health facilities (66% urban, 25% rural), and 39% were
attended by skilled providers (74% urban, 31% rural).
In Afghanistan’s tiered health system, health posts, basic
health centers, and comprehensive health centers (CHCs)
offer basic curative and preventive services at the commu-
nity level. The district hospital (or CHC where no district
hospital exists) serves as the link between primary care fa-
cilities and the network of referral hospitals. The sophisti-
cation level of health infrastructure and services increases
from district hospitals to provincial and regional hospitals
to national specialty hospitals. The Ministry of Public
Health of Afghanistan (MoPH) has designated 127 health
facilities to provide comprehensive EmONC services, in-
cluding all district, provincial, and regional hospitals, as
well as national hospitals specializing in maternity care
and certain CHCs in remote areas.
This study examines one part of the strategy to reduce
morbidity and mortality from PE/E in Afghanistan: im-
proving the treatment of severe PE/E. We performed a
further analysis of the 2009–10 Afghanistan Emergency
Obstetric and Newborn Care Needs Assessment [13] to
evaluate the capacity of EmONC facilities and their pro-
viders to manage severe PE/E cases.
Methods
In 2009–10, a needs assessment sought to examine
EmONC services at all 127 designated EmONC facilities;
however, 49 of those facilities (16 CHCs, 25 district hospi-
tals, five provincial hospitals and three national specialty
hospitals) were not accessible due to security constraints
[14]. The remaining 78 facilities constitute the study sam-
ple. They include nine CHCs, 34 district hospitals, 25 pro-
vincial hospitals, five regional hospitals, and five national
specialty hospitals. Two-thirds of the facilities are located
in urban areas. Although the study covered only 61% of
the government health facilities expected to provide
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31 of Afghanistan’s 34 provinces and assessed all facilities
in secure areas where it is possible for international
nongovernmental organizations (NGOs) to implement
health programs and conduct research. Two doctors and
two midwives responsible for providing EmONC services
were randomly selected to participate in the study at each
provincial, regional, and specialty hospital. Two providers,
including a doctor if one was available, were chosen to
participate at each district hospital and CHC.
The assessment team consisted of six doctors and 38
midwives. All were experienced service providers and had
helped collect data for previous studies in Afghanistan.
The assessors had one week of training, after which intra-
and inter-assessor reliability were tested. They visited each
facility for one to three days to collect data. Health facil-
ities were not informed in advance about the assessors’
visit. Upon arrival at each facility, assessors obtained con-
sent from the facility’s Medical Director and held an intro-
ductory meeting with key informants, including staff in
charge of maternity, surgery, pharmacy, and laboratory
departments.
To investigate the facility’s capacity to provide ANC,
labor, and delivery services, assessors made observations,
interviewed key informants, and reviewed records, using
tools based on a Needs Assessment Toolkit developed by
the Averting Maternal Death and Disability (AMDD) Pro-
gram [15]. Assessors also interviewed providers regarding
their training on and experience with focused ANC and
treatment of severe PE/E. A written case scenario was
used to evaluate providers’ knowledge and clinical judg-
ment regarding severe PE/E. The case scenario described
a pregnant woman brought to the emergency department
of a district hospital after experiencing convulsions at
home. At each step in the scenario, providers were asked
how the case should be managed; they selected appropri-
ate actions from a list of possible options. The percentage
of providers who selected each correct response was cal-
culated. The case scenario instrument shows exactly what
background information was given to providers, along
with the questions and a list of all possible answers [see
Additional file 1].
The MoPH and National Reproductive Health Task
Force adapted AMDD observation, interview, and record
review tools for use in this study. They then led a work-
shop to review and revise the tools with national EmONC
trainers and experts from UNICEF, WHO, and NGOs
contracted by the MoPH to operate primary health faci-
lities. The PE/E case scenario was developed separately by
international experts at the Maternal and Child Health
Integrated Program (MCHIP). All tools, including the case
scenario, were pilot tested in Afghanistan during the asses-
sors’ training workshop. The study protocols were
approved by the Institutional Review Boards of theAfghanistan Public Health Institute and the Johns
Hopkins School of Public Health (IRB 2333 and IRB
2359).
Descriptive statistics were used to summarize facility and
provider characteristics. Student t-test, one-way ANOVA,
and chi-square tests were performed to determine whether
there were significant differences between types of facilities,
doctors and midwives, and trained and untrained providers.
Analyses were conducted using STATA 11.2 with a type 1
error of 0.05.Results
Caseloads, supplies, and drugs
The number of women with severe PE/E treated at
EmONC facilities varied widely. The median number of
severe PE/E cases in the past year was just 5 (range 0–42)
at CHCs and district hospitals, compared with 44 (range
0–130) at provincial hospitals and 108 (32–540) at re-
gional and specialized hospitals (p < 0.001) (Table 1). This
reflects variations in the size and caseload at different
types of EmONC facilities: the median number of vaginal
deliveries documented in maternity ward logbooks ranged
from 1,078 (range 76–7,002) deliveries per year at CHCs
and district hospitals to 7,516 (range 920–43,772) at pro-
vincial hospitals and 35,182 (range 6,368–82,124) at re-
gional and specialized hospitals.
On the day of the survey, pertinent service delivery guide-
lines were available in 83.7% to 100% of facilities (Table 1).
Blood pressure cuffs and stethoscopes were available at all
facilities, and three-fifths had urine test strips to check for
proteinuria. From 76.7% to 96% of facilities had a complete
IV set to maintain fluid balance and administer anti-
hypertensives and MgSO4. There were no significant diffe-
rences in the availability of any of these items by facility
type. All but one CHC, one district hospital, and three pro-
vincial hospitals had anti-hypertensive drugs in stock.
Anticonvulsants were widely available, although not al-
ways used. MgSO4 was in stock at all regional and special-
ized hospitals and over 93% of other facilities. Diazepam
was almost as widely available, except at regional and spe-
cialized hospitals. With one exception, all facilities had ad-
ministered the preferred anticonvulsant, MgSO4. However,
33% of CHCs and district hospitals, 56% of provincial hos-
pitals, and 50% of regional and specialized hospitals had
administered diazepam in some cases as well. Only one
facility (a provincial hospital) reported administering di-
azepam but not MgSO4. Of the 10 CHCs and district hos-
pitals that had not recently administered anticonvulsants,
six reported that no women had required it and three did
not give any reason. Lack of supplies and equipment,
training issues, and availability of human resources
were additional reasons given for not administering
anticonvulsants.
Table 1 PE/E caseload, supplies, and equipment at health facilities, by facility type
Item CHCs and district
hospitals (n = 43)
Provincial
hospitals (n = 25)
Regional and specialized
hospitals (n = 10)
p-value
No. of vaginal deliveries in last 12 months
Median 1,078 7,516 35,182 <0.001
Range 76–7,002 920–43,772 6,368–82,124
No. of PE/E cases in last 12 months
Median 5 44 108 <0.001
Range 0–42 0–130 32–540
At least one PE/E case treated in past 3 months (%) 72.1 100.0 100.0 0.003
Guidelines present in maternity ward (%)
Focused ANC 88.4 92.0 100.0 0.500
Management of obstetric complications 83.7 88.0 100.0 0.378
Supplies and equipment available (%)
BP cuff and stethoscope 100.0 100.0 100.0 1.000
Urine test strips 62.8 64.0 60.0 1.000
Complete IV seta 76.7 96.0 80.0 0.088
Any anti-hypertensive available (%)b 95.4 88.0 100.0 0.404
Anticonvulsants available (%)
MgSO4 93.0 96.0 100.0 1.000
Diazepam 90.7 96.0 70.0 0.090
Among facilities that administered anticonvulsants
in last 3 months, drugs (%) used
(n = 33) (n = 25) (n = 10)
MgSO4 only 66.6 40.0 50.0 0.449
Diazepam only 0 4.0 0
Both drugs 33.3 56.0 50.0
aIncludes IV cannulae, catheter for IV line, and IV infusion stand.
bHydralazine, methyldopa, and/or nefedipine.
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Fewer doctors than midwives participated in the study (82
and 142, respectively), but all were female, by cultural
preference. Only a small proportion of the providers (27%
of doctors and 14% of midwives) worked at large regional
and specialized hospitals (Table 2). The median years of
experience offering EmONC services was five years for
doctors and four years for midwives; their training, experi-
ence, and confidence levels in providing focused ANC
were also similar.
There was no significant difference in the proportion
of doctors and midwives who had received in-service
training on the use of MgSO4 to treat severe PE/E (82%
and 79%). Doctors had administered anticonvulsants to
significantly more women than the midwives had, on
average, in the preceding three months (median of five
and three women, respectively). However, individual
providers had widely varying experience with anticonvul-
sants: the number of women to whom they had given
anticonvulsants in the past three months ranged from a
low of zero to a high of 65. Providers’ confidence in their
ability to administer anticonvulsants was generally high:83% of doctors and 79% of midwives said they felt very
confident. However, almost twice as many midwives as
doctors (16% versus 8.5%, p < 0.01) expressed some res-
ervations, saying they were in need of coaching.
Case management
Providers’ knowledge and decision-making skills related to
severe PE/E were tested with a case scenario describing a
pregnant woman who came to the emergency department
after having convulsions at home. Each part of the sce-
nario is described in detail below.
Part one asked providers what information must be
obtained immediately in order to initiate emergency man-
agement of the woman’s most urgent condition. A large
majority of doctors and midwives (from 83.6% to 96.9%)
correctly identified three pieces of information on the
woman’s status: vital signs, level of consciousness, and
presence of current convulsions (Table 3). There were no
significant differences by provider type. Knowledge was
significantly higher among providers who had received
training on MgSO4 compared to untrained providers for
presence of current convulsions (69.4% versus 90.5%, p <
Table 2 Providers’ workplace, experience, and training, by provider type
Doctors (n = 82) Midwives (n = 142) p-value
Location of work (%)
CHC or district hospital 30.4 44.5 0.079
Provincial hospital 43.0 41.6
Regional hospital or specialized hospital 26.5 13.9
Years of experience offering EmONC: median (range) 5 (1–22) 4 (1–32) 0.781
Focused ANC
Has received training (%) 77.6 81.2 0.430
Number of cases attended in last 3 months: median (range)a 60 (0–900) 100 (0–855) 0.0903
Confidence in providing care (%):
Very confident 86.7 87.4 0.896
Somewhat confident (needs coaching) 12.0 11.1
Not confident 1.3 1.5
Treatment of severe PE/E
Has received training on MgSO4 (%) 82.1 78.6 0.714
Number of cases given anticonvulsants in last 3 months: median (range)a 5 (0–65) 3 (0–50) 0.031
Confidence in administering anticonvulsants (%):
Very confident 83.1 79.2 0.01
Somewhat confident (needs coaching) 8.5 16.0
Not confident 8.5 4.8
an = 76 doctors and 135 midwives for number of cases attended in last 3 months.
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cantly lower at CHCs and district hospitals than at provin-
cial hospitals or at regional and specialized hospitals
(80.3% versus 93.3% and 90.9%, p < 0.05).
Part two asked providers to diagnose the woman’s con-
dition based on the results of a clinical exam. The correct
answer, eclampsia, was given by 77.2% of doctors and
62.3% of midwives. All but two of the remaining providers
diagnosed pre-eclampsia instead. There were no signifi-
cant differences in diagnosis by provider type, training, or
facility type.
Part three asked providers to select appropriate actions
to manage the most urgent presenting condition. A large
majority (96.2% of doctors and 88.5% of midwives) recog-
nized the need to give MgSO4, but less than half (44.3% of
doctors and 42.5% of midwives) noted the need for con-
tinuous bedside care until the woman is stable with hourly
observations thereafter. Providers trained on the use of
MgSO4 were significantly more likely than others to iden-
tify the need for the drug (93.3% versus 82.3%, p < 0.05),
but were less likely to select continuous bedside care
followed by hourly observations (58.3% versus 38.2%, p <
0.05). Providers working at CHCs and district hospitals
were significantly less likely than providers at larger facil-
ities to recognize the need for bed rest (31.4% versus
53.7% and 50%, p < 0.01).
Part four asked what immediate actions providers
should take if a woman had a convulsion at the time ofadmission. Over four-fifths of providers (81.3% to 88.6%)
said to administer oxygen and to place the woman in a
side-lying position; slightly fewer (75% to 79.2%) said to
protect the woman from injury. There were no signifi-
cant differences by provider type, training, or facility
type. Notably, around half of providers (42% of doctors
and 58% of midwives, p < 0.05) mentioned the need for
intravenous diazepam, a second-line drug recommended
only in the absence of MgSO4; there was no significant
difference by facility type (data not shown). Providers
who received training on MgSO4 were less likely than
other providers to call for giving diazepam (38% versus
53%), but the difference was not statistically significant.
Part five asked providers which equipment and supplies
must be available to best manage the woman’s most ur-
gent condition. A large majority (from 78% to 91%) cor-
rectly identified an IV line, urinary catheter, suction
catheter, and oxygen. There was no significant difference
between doctors and midwives, but providers trained on
MgSO4 were significantly more likely than others to iden-
tify oxygen and an adult mask (89% versus 77%, p < 0.05).
Providers working at CHCs and district hospitals were sig-
nificantly less likely than those at larger facilities to iden-
tify urinary catheters (74.4% versus 90.5% and 89.4%, p <
0.01) and suction catheters (68.6% versus 87.4% and
92.1%, p < 0.001). Many providers (39% of doctors and
55% of midwives) also believed that it was essential to have
equipment available to administer intravenous diazepam,
Table 3 Case management: percentage of providers responding correctly to case scenario related to severe pe/e symptoms, by provider type, provider
training, and facility type
Provider type Provider training Facility type

















hospitals (n = 10)
p-
value
I. Information needed immediately to start emergency management (%)
Level of consciousness 92.2 83.6 0.228 80.0 89.7 0.076 80.3 93.3 90.9 0.046
Presence of current convulsions 88.4 87.3 0.949 69.4 90.5 <0.001 80.0 92.3 91.1 0.082
Vital signs 96.9 96.4 0.929 100.0 95.8 0.214 97.0 96.3 97.0 0.970
II. Diagnosis of eclampsia (%)
Diagnosis of eclampsia 77.2 62.3 0.120 66.7 67.8 1.000 60.5 66.3 81.1 0.282
III. Urgent actions to manage presenting condition (%)
Bed resta 44.3 42.5 0.725 58.3 38.2 0.019 31.4 53.7 50.0 0.008
MgSO4 96.2 88.5 0.051 82.3 93.3 0.035 87.2 92.6 94.7 0.297
IV. Immediate actions if woman is having convulsions when admitted (%)
Give oxygen at 4–6 L per min. 88.6 81.3 0.153 83.3 86.0 0.638 79.1 85.3 92.1 0.171
Place in side-lying position 88.6 85.6 0.622 77.1 87.6 0.098 83.7 92.6 78.9 0.062
Protect woman from injury 79.2 75.0 0.696 75.0 75.8 1.000 68.6 78.9 86.8 0.064
V. Essential equipment and supplies to manage most urgent condition (%)
IV with saline or Ringers Lactate 78.4 87.7 0.070 83.3 83.7 0.823 83.7 86.3 76.3 0.372
Indwelling urinary catheter/ bag 87.0 83.1 0.361 85.4 82.6 0.830 74.4 90.5 89.4 0.008
Suction and suction catheter 87.3 78.2 0.098 68.8 76.4 0.335 68.6 87.4 92.1 0.001
Oxygen and adult mask 91.1 84.2 0.142 77.1 88.8 0.049 82.6 87.4 86.8 0.633
VI. Appropriate actions after convulsions are controlled (%)
Repeat dose of MgSO4 in 4 hours 71.4 77.9 0.301 64.6 77.5 0.083 74.4 73.7 84.2 0.409
Continue anti-hypertensives 81.0 66.2 0.024 56.3 74.7 0.016 70.9 67.4 81.6 0.072
Monitor labor, begin partograph 79.2 80.9 0.532 77.3 81.4 0.672 72.1 89.5 79.0 0.262
Check respirations hourly (auscultate
lungs if needed)
59.5 54.7 0.683 35.4 61.8 0.002 50.0 62.1 60.1 0.012
Document intake/output hourly 75.9 69.1 0.269 68.8 71.4 0.854 62.8 76.8 73.7 0.232
VII. Appropriate actions after vaginal delivery (%)
Continue MgSO4 for 24 hours 80.5 77.2 0.995 72.7 80.8 0.302 72.1 83.2 84.2 0.130
Assess vital signs every 15 minutes
for 2 hours after birth
90.9 90.4 0.652 88.6 91.6 0.771 91.9 92.6 84.2 0.288
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provider training (data not shown).
Part six asked providers what actions were appropriate
one hour following the initiation of treatment if the woman
still had a moderate headache but no further convulsions.
From 55% to 81% of providers identified each of the five
correct responses. Doctors were significantly more likely
than midwives to recognize the need to continue use of
anti-hypertensives to maintain diastolic blood pressure
between 90–100 mm Hg (81% versus 66.2%, p < 0.05).
Trained providers were significantly more likely than
others to identify continued use of anti-hypertensives
(74.7% versus 56.3%, p < 0.05) and checked respirations
every hour, auscultating the lungs if necessary (35.4% ver-
sus 61.8%, p < 0.001). Regularly checking the respiratory
rate is especially important because most health facilities in
Afghanistan lack oximeters to check oxygen saturation.
The final part of the scenario asked providers what ac-
tions were appropriate after the woman had a spontaneous
vaginal delivery. A large majority of providers recognized
the need to continue MgSO4 for 24 hours after birth
(80.5% of doctors and 77.2% of midwives) and assess vital
signs every 15 minutes during the first two hours after birth
(90.9% of doctors and 90.4% of midwives). There were no
significant differences by provider type, facility type, or pro-
vider training.
Overall, providers who had been trained on the treat-
ment of severe PE/E scored significantly higher than un-
trained providers on six out of 20 items in the case
scenario. There were significant differences by facility type
for five out of the 20 items; providers at CHCs and district
hospitals scored lower than providers at larger hospitals.
Finally, there was a significant difference between doctors
and midwives on just one item: continued use of anti-
hypertensives after convulsions are controlled.
Discussion
Most women in Afghanistan deliver at home and must
overcome long distances, difficult terrain, poor roads, and
limited transportation to get to health facilities if they suf-
fer complications [16]. It is essential that providers have
the knowledge, skills, supplies, and equipment needed to
immediately diagnose and address complications. Our
findings show that most EmONC facilities and providers
in Afghanistan are relatively well-prepared to manage
severe PE/E cases, but certain weaknesses need to be
addressed.
Managing hypertension and preventing convulsions are
key elements in treating severe PE/E. All assessed facilities
had blood pressure cuffs and stethoscopes on hand, and a
large majority had anti-hypertensive drugs in stock. How-
ever, the case scenario found that about one-fifth of doc-
tors and one-third of midwives did not correctly identify
the need to continue administering anti-hypertensivesafter delivery in cases of PE/E. This finding suggests that a
substantial portion of women with PE/E may not be
treated for hypertension after delivery.
While any of several anti-hypertensive drugs may be
used to treat severe PE/E [7], MgSO4 is the clear drug of
choice to prevent convulsions, and its potential impact on
maternal morbidity and mortality is considerable. In
Nigeria, for example, the case fatality rate for severe PE/E
at hospitals in Kano fell from 20.9% to 2.3% after MgSO4
was introduced; perinatal mortality also fell significantly
[17]. The drug has been identified in a list of 13 affordable,
effective, but underutilized lifesaving commodities by the
United Nations Commission on Life-Saving Commodities
for Women and Children [18].
However, this study found that many EmONC facilities
in Afghanistan—including half of provincial, specialized,
and regional hospitals—are continuing to administer di-
azepam to some patients with severe PE/E. The transition
from using diazepam to using MgSO4 in the treatment of
severe PE/E has lagged in many countries. Common ob-
stacles include inappropriate policies, limited supplies,
lack of training, and misperceptions about use of MgSO4
[19]. A 2012 survey of 37 countries suggested that policy
for and access to MgSO4 is improving, but that additional
support is needed regarding provider competence and
confidence in its use [20]. In Afghanistan, policy does not
present a barrier to the use of MgSO4 because national
guidelines exist and MgSO4 is included in the MoPH’s Es-
sential Drug List. Our findings indicate that supply is not
a major problem either, given that the drug was in stock at
nearly all assessed facilities. Rather, the case scenario sug-
gests that confusion remains in the minds of many pro-
viders regarding the role of diazepam.
Training on the use of MgSO4—part of in-service
EmONC training for midwives and doctors in Afghanistan—
was associated with better decision-making on six items in
the case scenario. However, training did not make a sig-
nificant difference in providers’ decisions on diazepam, in
part because the EmONC training package identifies di-
azepam as an alternative drug for the management of se-
vere PE/E when MgSO4 is not available. Two dozen other
countries also have concurrent approval of diazepam and
MgSO4 as first-line anticonvulsants, which present a po-
tentially confusing scenario for health care providers [20].
Lack of understanding of how MgSO4 should be adminis-
tered and persistent concerns about side effects, despite
evidence of the drug’s safety in low-resource settings, also
contribute to providers’ reluctance to administer the drug
[21]. Further refresher training, accompanied by post-
training follow-up, supportive supervision, consistent
training manuals and job aids, is essential to help Afghan
providers understand that MgSO4 is safe and should be
preferred over diazepam whenever it is available. But stu-
dies suggest that training alone may not be sufficient to
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example, a training intervention on severe PE/E raised
providers’ test scores, but they remained hesitant about
administering MgSO4 [22]. Without a ready supply of
MgSO4, an easily accessible treatment protocol, super-
vision, and reinforcement of best practices after train-
ing, providers may not change established prescribing
habits and switch from diazepam to MgSO4.
Low caseloads may blunt the impact of training, and
sustaining competence with limited opportunities to prac-
tice is a challenge. In Zambia, for example, where lack of
in-service training posed a barrier to the use of MgSO4,
the infrequency of pre-eclampsia cases at small hospitals
exacerbated the problem by limiting providers’ exposure
to the condition and opportunity to practice [23]. Our
data suggest that this is potentially a problem at CHCs
and district hospitals in Afghanistan, which may see only a
handful of cases of severe PE/E each year. Providers working
at smaller facilities also tend to have limited opportunities
for learning and few, if any, colleagues to confer with. These
disadvantages may explain why providers at CHCs and
district hospitals scored significantly lower on five items
in the clinical scenario. Providers at these facilities would
benefit from regular refresher courses that include clinical
simulations on severe PE/E, along with ready access to job
aids, decision-making charts, and fully equipped emergency
kits [24]. In Senegal, clinical audits of charts for all pregnant
women with hemorrhagic and hypertensive complications
also promoted correct diagnosis and treatment [25].
While providers scored well on many areas in the case
scenario, there is room for improvement, especially in man-
aging patients with eclampsia after convulsions are con-
trolled. The need to strengthen knowledge on severe PE/E
is not unique to Afghanistan: in an evaluation of skilled
birth attendants in Benin, Ecuador, Jamaica, and Rwanda,
mean knowledge scores for pregnancy-induced hyperten-
sion ranged from 52% to 78%. There was greater disparity
in doctors’ and midwives’ knowledge of hypertension (75%
and 58%, respectively) than their knowledge of other topics
[26]. This finding stands in marked contrast to the situation
in Afghanistan, where doctors and midwives had similar
scores on the case scenario and shared the same strengths
and weaknesses, with one exception (continuing to use
anti-hypertensives to maintain diastolic pressure after con-
vulsions are controlled). The similarity in the capacity of
doctors and midwives is notable and somewhat unique. It
may be due to the team approach to in-service EmONC
training adopted by the MoPH, and increasingly common
globally, which can help different health cadres understand
each other’s roles and promote greater collaboration and
more effective teamwork [24].
While this study focuses on appropriate treatment of
severe PE/E, reducing morbidity and mortality requires
action outside of—and long before women arrive at—EmONC facilities. For example, calcium supplementation
during pregnancy can prevent PE/E in countries like
Afghanistan, where pregnant women get little calcium as
part of their diet [7,27]. Likewise, routinely screening for
hypertension, proteinuria, and danger signs during ANC
visits can detect cases of pre-eclampsia and prevent them
from progressing to eclampsia [27-29]. Raising community
awareness of warning signs of eclampsia, such as head-
ache, visual disturbances, and epigastric pain, can prompt
women to seek care in a timely manner [17,30]. The weak-
nesses identified in the management of severe PE/E cases
at EmONC facilities suggest that frontline health workers
in Afghanistan may also suffer from limited knowledge,
skills, and supplies. Further research on the capacity of
community health workers who provide ANC in the com-
munity and at health posts in Afghanistan is needed to
complement this study.
Study strengths and limitations
This study used a case scenario to assess providers’ cap-
acity to manage severe PE/E cases. Clinical vignettes of
this kind are a validated method to assess the quality of
clinical practice that has been applied in both low- and
high-income countries [31,32]. They provide a simple and
inexpensive way to assess how well providers apply know-
ledge and decision-making skills to realistically complex
scenarios and have proven especially useful for comparing
sites and settings. In this study, use of a case scenario per-
mitted us to measure the impact of the facility setting and
provider characteristics on case management.
Interpretation of the findings is subject to certain limita-
tions. First, the assessment is not representative of the en-
tire country, because security concerns limited the number
and locations of facilities assessed. Second, the sampling
strategy underrepresented providers at larger facilities who
may have stronger skills, although fewer providers were se-
lected from CHCs and district hospitals than provincial, re-
gional, and specialized facilities. Third, no validity study
has been conducted on the case scenario used in this as-
sessment, although the tool was based on best practices.
Fourth, it is not possible for a single case scenario to test
providers’ case management skills in a variety of situations
as, for example, when a woman develops severe PE/E post-
partum. Fifth, contradictions between different information
sources, such as interviews and registers, suggest that data
on services offered at each facility may be subject to recall
and reporting bias.
Conclusions
Drugs and supplies to treat severe PE/E are widely avail-
able at EmONC facilities in Afghanistan, but providers’
knowledge is insufficient in some areas, especially regard-
ing the decision to use MgSO4 instead of diazepam. Pro-
viders who have received specific training on PE/E or who
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vere PE/E proved to have stronger case management
skills. This suggests a need to: clarify service delivery
guidelines, especially regarding anticonvulsants, and revise
job aids and training materials accordingly; offer refresher
training to providers who work at facilities with low case-
loads; and reinforce best practices with supervision and
other reinforcement activities. In particular, training ef-
forts should place further emphasis on the superiority of
MgSO4 over diazepam and on the need to continue anti-
hypertensive treatment after delivery. The study findings
will be used to help inform continuing education and
reinforcement efforts in Afghanistan and also to standardize
supplies and equipment across different facility levels. More
broadly, they can contribute to the development of effective
strategies for translating health worker knowledge into
practice in low-income countries.
Additional file
Additional file 1: Case Scenario. EmONC Needs Assessment in
Afghanistan: Clinical Decision-Making Case Scenario 1. Care to Mother in
Maternity Ward – Headache, blurred vision, convulsions or loss of
consciousness, elevated blood pressure.
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